Rapid achievement of low-density lipoprotein cholesterol goals within 1 month after acute coronary syndrome during combination therapy with rosuvastatin, ezetimibe and bempedoic acid: Initial experience from the LAI-REACT study
Kunal Mahajan, Raman Puri, P. Barton Duell, Deep Dutta, Rahul Yadav, Surender Kumar, Jai Bharat Sharma, Prashant Patel, Savio Dsouza, Ashu Gupta, Aziz Khan, Nathan D. Wong
Topics & Concepts
MedicineEzetimibeRosuvastatinAcute coronary syndromeInternal medicineCombination therapyCholesterolCardiologyGastroenterologyMyocardial infarctionLipoproteins and Cardiovascular HealthHealth Systems, Economic Evaluations, Quality of LifeAntiplatelet Therapy and Cardiovascular Diseases